Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab

Cecilie Heegaard Brahe, Mikkel Østergaard, Julie S. Johansen, Nadine A. Defranoux, Xingbin Wang, Rebecca J. Bolce, Eric H. Sasso, Kim Hørslev-Petersen, Kristian Stengaard-Pedersen, Lykke Midtbøll Ornbjerg, Peter Junker, Torkell Juulsgaard Ellingsen, Palle Ahlquist, Hanne Merete Lindegaard, Asta Linauskas, Annette Schlemmer, Mette Yde Dam, Ib T Hansen, Tine Lottenburger, Christian Gytz AmmitzbøllAnette Jørgensen, Sophine B. Krintel, Johnny Lillelund Raun, Merete Lund Hetland

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date15. Nov 2016
Publication statusPublished - 15. Nov 2016
EventACR/ARHP Annual Meeting - Washington , United States
Duration: 11. Nov 201616. Nov 2016

Conference

ConferenceACR/ARHP Annual Meeting
CountryUnited States
CityWashington
Period11/11/201616/11/2016

Cite this

Brahe, C. H., Østergaard, M., Johansen, J. S., Defranoux, N. A., Wang, X., Bolce, R. J., Sasso, E. H., Hørslev-Petersen, K., Stengaard-Pedersen, K., Ornbjerg, L. M., Junker, P., Ellingsen, T. J., Ahlquist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I. T., Lottenburger, T., ... Hetland, M. L. (2016). Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab. Poster session presented at ACR/ARHP Annual Meeting, Washington , United States.